Overview

Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria

Status:
RECRUITING
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to evaluate the efficacy and safety of cetirizine hydrochloride injection in the treatment of acute urticaria.The participants were randomized to receive cetirizine hydrochloride or diphenhydramine hydrochloride.
Phase:
PHASE3
Details
Lead Sponsor:
Shandong New Time Pharmaceutical Co., LTD
Treatments:
Cetirizine
Diphenhydramine